Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 16 Jun 2008):

Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.

Full Abstract

The symptoms of major psychotic illness are diverse and vary widely across individuals. Furthermore, the prepsychotic phase is indistinct, providing little indication of the precise pattern of symptoms that may subsequently emerge. Likewise, although in some individuals who have affected family members the occurrence of disease may be predicted, the specific symptom profile may not. An important question, therefore, is whether predictive physiological markers of symptom expression can be identified. We conducted a placebo-controlled, within-subjects study in healthy individuals to investigate whether individual variability in baseline physiology, as assessed using functional magnetic resonance imaging, predicted psychosis elicited by the psychotomimetic drug ketamine and whether physiological change under drug reproduced those reported in patients. Here we show that brain responses to cognitive task demands under placebo predict the expression of psychotic phenomena after drug administration. Frontothalamic responses to a working memory task were associated with the tendency of subjects to experience negative symptoms under ketamine. Bilateral frontal responses to an attention task were also predictive of negative symptoms. Frontotemporal activations during language processing tasks were predictive of thought disorder and auditory illusory experiences. A subpsychotic dose of ketamine administered during a second scanning session resulted in increased basal ganglia and thalamic activation during the working memory task, paralleling previous reports in patients with schizophrenia. These results demonstrate precise and predictive brain markers for individual profiles of vulnerability to drug-induced psychosis.

 

Learn Faster Today      Improve your study skills

Author information

Author/s: Honey, Garry D (GD); Corlett, Philip R (PR); Absalom, Anthony R (AR); Lee, Michael (M); Pomarol-Clotet, Edith (E); Murray, Graham K (GK); McKenna, Peter J (PJ); Bullmore, Edward T (ET); Menon, David K (DK); Fletcher, Paul C (PC);

Affiliation: Department of Psychiatry, Brain Mapping Unit and Behavioural and Clinical Neurosciences Institute, University of Cambridge, School of Clinical Medicine, Cambridge CB2 2QQ, United Kingdom.

Grants: (Agency:United Kingdom Wellcome Trust)

Journal and publication information

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci), published in United States. (Language: eng)

Reference: 2008-Jun; vol 28 (issue 25) : pp 6295-303

Dates: Created 2008/06/19; Completed 2008/07/10;

PMID: 18562599, status: MEDLINE (last retrieval date: 11/6/2008)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article (including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Placebos (0) ; Ketamine (6740-88-1)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

10/1/2005
3/31/2008
Higher Relevance Score (440/1000)
Lower Relevance Score (359/1000)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy.com 2003-2008 (ACN 104 198 263) - All rights reserved. Terms of Use | Contact Us | Index